Moreover, PSMA-PET was superior to FDG-PET in detecting ICC and HCC, indicating that PSMA-PET may be used as alternative staging and to identify patients for PSMA-targeted therapy. Here, FOLH1 is linked to intrahepatic cholangiocarcinoma.